
The story of American innovation has always hinged on a singular question: When the moment comes, will we move with intention, or hesitate until it’s too late? On April 8th, 2025, the National Security Commission on Emerging Biotechnology (NSCEB) dropped its final report. A 195-page beast of a document. Dense, detailed, and urgent. The kind of thing Washington usually takes months to digest, if it bothers to read it at all. But this time?